162 related articles for article (PubMed ID: 28427173)
1. Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites.
Cheng J; Guo Y; Gao Q; Li H; Yan H; Li M; Cai H; Zheng W; Li X; Jiang W; Guo Z
Oncotarget; 2017 May; 8(18):30265-30275. PubMed ID: 28427173
[TBL] [Abstract][Full Text] [Related]
2. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.
Chen R; Guan Q; Cheng J; He J; Liu H; Cai H; Hong G; Zhang J; Li N; Ao L; Guo Z
Oncotarget; 2017 Jan; 8(4):6652-6662. PubMed ID: 28036264
[TBL] [Abstract][Full Text] [Related]
3. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
[TBL] [Abstract][Full Text] [Related]
4. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
[TBL] [Abstract][Full Text] [Related]
5. A qualitative transcriptional signature to reclassify estrogen receptor status of breast cancer patients.
Cai H; Guo W; Zhang S; Li N; Wang X; Liu H; Chen R; Wang S; Guo Z; Li J
Breast Cancer Res Treat; 2018 Jul; 170(2):271-277. PubMed ID: 29572677
[TBL] [Abstract][Full Text] [Related]
6. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.
Cheng J; Guo Y; Guan G; Huang H; Jiang F; He J; Wu J; Guo Z; Liu X; Ao L
J Cell Mol Med; 2021 Apr; 25(7):3622-3633. PubMed ID: 33719152
[TBL] [Abstract][Full Text] [Related]
7. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
[TBL] [Abstract][Full Text] [Related]
8. Robust transcriptional signatures for low-input RNA samples based on relative expression orderings.
Liu H; Li Y; He J; Guan Q; Chen R; Yan H; Zheng W; Song K; Cai H; Guo Y; Wang X; Guo Z
BMC Genomics; 2017 Nov; 18(1):913. PubMed ID: 29179677
[TBL] [Abstract][Full Text] [Related]
9. A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer.
Yan H; Li M; Cao L; Chen H; Lai H; Guan Q; Chen H; Zhou W; Zheng B; Guo Z; Zheng C
J Transl Med; 2019 Feb; 17(1):63. PubMed ID: 30819200
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Age, Cigarette Smoking, Sex, and Race on the Qualitative Characteristics of Lung Transcriptome.
Guan Q; Zhang J; Guo Y; Xia J; Zhang J; Xie J; Cai H; Yan H; Wang X; Guo Z
Biomed Res Int; 2020; 2020():6418460. PubMed ID: 32802863
[TBL] [Abstract][Full Text] [Related]
11. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms.
Guan Q; Chen R; Yan H; Cai H; Guo Y; Li M; Li X; Tong M; Ao L; Li H; Hong G; Guo Z
Oncotarget; 2016 Oct; 7(42):68909-68920. PubMed ID: 27634898
[TBL] [Abstract][Full Text] [Related]
12. Identification of gene signatures for invasive colorectal tumor cells.
Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.
Cai H; Li X; Li J; Ao L; Yan H; Tong M; Guan Q; Li M; Guo Z
Oncotarget; 2015 Dec; 6(42):44593-608. PubMed ID: 26527319
[TBL] [Abstract][Full Text] [Related]
14. Identification of a seven autophagy-related gene pairs signature for the diagnosis of colorectal cancer using the RankComp algorithm.
Song QS; Wu HJ; Lin Q; Tang YK
J Bioinform Comput Biol; 2023 Jun; 21(3):2350012. PubMed ID: 37325865
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of genes with absolute mRNA abundances changes in tumor cells with varied transcriptome sizes.
Cai H; Li X; He J; Zhou W; Song K; Guo Y; Liu H; Guan Q; Yan H; Wang X; Guo Z
BMC Genomics; 2019 Feb; 20(1):134. PubMed ID: 30760197
[TBL] [Abstract][Full Text] [Related]
16. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
[TBL] [Abstract][Full Text] [Related]
17. A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.
Zhao W; Chen B; Guo X; Wang R; Chang Z; Dong Y; Song K; Wang W; Qi L; Gu Y; Wang C; Yang D; Guo Z
Oncotarget; 2016 Apr; 7(14):19060-71. PubMed ID: 26967049
[TBL] [Abstract][Full Text] [Related]
18. Prognostic stromal gene signatures in breast cancer.
Winslow S; Leandersson K; Edsjö A; Larsson C
Breast Cancer Res; 2015 Feb; 17(1):23. PubMed ID: 25848820
[TBL] [Abstract][Full Text] [Related]
19. Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning.
He J; Yan H; Cai H; Li X; Guan Q; Zheng W; Chen R; Liu H; Song K; Guo Z; Wang X
J Transl Med; 2017 Sep; 15(1):198. PubMed ID: 28962576
[TBL] [Abstract][Full Text] [Related]
20. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
